Breathing Labs
Home
How To Start
Products
Breathing+ Package
Toys Package
Q&A
Login

Covid19

25Dec

Remdesivir only for moderate to severely affected: Centre

Posted by: admin Categories: Covid19
Comments Off on Remdesivir only for moderate to severely affected: Centre

The Centre on Friday specified the conditions for the administration of the Remdesivir drug. The drug should be used only in patients with moderate to severe COVID-19 and not for those who are not on oxygen support or those in home settings. Furthermore, it must be administered only to those with no renal or hepatic […]

Read more
24Dec

EXPLAINER: What COVID-19 therapies are available in US?

Posted by: admin Categories: Covid19
Comments Off on EXPLAINER: What COVID-19 therapies are available in US?

By MATTHEW PERRONEAP Health Writer WASHINGTON (AP) — Two antiviral pills are the latest additions to the handful of therapies to treat COVID-19 in the U.S. The Food and Drug Administration authorized the drugs from Merck and Pfizer as the first treatments that patients can take at home to treat mild-to-moderate symptoms. The drugs are […]

Read more
24Dec

Health Ministry says remdesivir will be used in patients with moderate to severe Kovid-19

Posted by: admin Categories: Covid19
Comments Off on Health Ministry says remdesivir will be used in patients with moderate to severe Kovid-19

New Delhi, December 24 The Center on Friday said the drug Remdesivir should be used only in patients with ‘moderate to severe’ COVID-19 and patients with kidney or liver dysfunction within 10 days of the onset of any symptoms. It also warned against the use of the drug in patients who are not on oxygen […]

Read more
23Dec

Hospital staff cheers for Cloquet man who survived COVID-19

Posted by: admin Categories: Covid19
Comments Off on Hospital staff cheers for Cloquet man who survived COVID-19

DULUTH, MN. (KBJR) – An emotional goodbye at a hospital has become all too common in the pandemic. But for one goodbye at Community Memorial in Cloquet on Wednesday, the emotion took on a different tone, joy. “I have so much joy. I can’t explain it all,” said Steven Jarve, a patient at Community Memorial […]

Read more
18Dec

Table: Remdesivir Clinical Data | COVID-19 Treatment Guidelines

Posted by: admin Categories: Covid19
Comments Off on Table: Remdesivir Clinical Data | COVID-19 Treatment Guidelines

ACTT-1: Multinational, Placebo-Controlled, Double-Blind RCT of Remdesivir in Hospitalized Patients With COVID-191 Key Inclusion Criteria: Laboratory-confirmed SARS-CoV-2 infection ≥1 of the following criteria: Pulmonary infiltrates SpO2 ≤94% on room air Need for supplemental oxygen, high-flow oxygen, NIV, MV, or ECMO Key Exclusion Criteria: ALT or AST >5 times ULN eGFR <30 mL/min Pregnancy or breastfeeding […]

Read more
18Dec

Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports

Posted by: admin Categories: Covid19
Comments Off on Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports

This article was originally published here Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7390-7397. doi: 10.26355/eurrev_202112_27435. ABSTRACT OBJECTIVE: Although remdesivir (GS-5734) has recently demonstrated clinical benefits against the pandemic outbreak of coronavirus disease 2019 (COVID-19), neuropsychological adverse reactions (ADRs) remain to be examined in real-world settings. Therefore, we aimed to identify and characterize the neuropsychological ADRs […]

Read more
17Dec

Table: Characteristics of Antiviral Agents

Posted by: admin Categories: Covid19
Comments Off on Table: Characteristics of Antiviral Agents

RemdesivirApproved by the FDA for the treatment of COVID-19 in individuals aged ≥12 years and weighing ≥40 kg. Please see Therapeutic Management of Hospitalized Adults With COVID-19 for the Panel’s recommendations on when to use RDV. For Hospitalized Adults and Children (Aged ≥12 Years and Weighing ≥40 kg): RDV 200 mg IV on Day 1, […]

Read more
15Dec

Remdesivir vs Ivermectin – North Carolina Citizens for Constitutional Rights

Posted by: admin Categories: Covid19
Comments Off on Remdesivir vs Ivermectin – North Carolina Citizens for Constitutional Rights

John Droz has written a well researched critique of the FDA’s approval of Remdesivir and its refusal to approve Ivermectin. His analysis proves that the FDA is driven by greed, not science. The report is well written and well documented, with a clear side by side comparison of the data, which shows that Ivermectin is […]

Read more
15Dec

Lilly sees 2022 profit above estimates on boost from potential new drugs

Posted by: admin Categories: Covid19
Comments Off on Lilly sees 2022 profit above estimates on boost from potential new drugs

By Mrinalika Roy (Reuters) – Eli Lilly on Wednesday forecast 2022 profit above Wall Street estimates as it bets on new drug approvals to counter the impact of competition and pricing pressures on its other key treatments, sending its shares up nearly 10%. The company has plans to launch five more medicines over the next […]

Read more
15Dec

RCSB PDB – 7QG7: SARS-CoV-2 macrodomain Nsp3b bound to the remdesivir nucleoside GS-441524

Posted by: admin Categories: Covid19
Comments Off on RCSB PDB – 7QG7: SARS-CoV-2 macrodomain Nsp3b bound to the remdesivir nucleoside GS-441524

U08 (Subject of Investigation/LOI)Query on U08 Download Ideal Coordinates CCD File&nbsp Download Instance Coordinates  SDF format, chain C [auth A] SDF format, chain F [auth B] MOL2 format, chain C [auth A] MOL2 format, chain F [auth B] C [auth A], F [auth B] (2~{R},3~{R},4~{S},5~{R})-2-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolane-2-carbonitrileC12 H13 N5 O4BRDWIEOJOWJCLU-LTGWCKQJSA-N  Ligand Interaction Source link

Read more
13Dec

Remdesivir Recall – Top podcast episodes

Posted by: admin Categories: Covid19
Comments Off on Remdesivir Recall – Top podcast episodes

Put this image on your website to promote the show – Get embed code <a href=”” title=””><img loading=”lazy” src=”” alt=”” style=”height: 120px; max-width: 100%;” /></a> What is Listen Score? Listen Score (LS) is a metric that shows the estimated popularity of this podcast compared to other rss-based public podcasts in the world on a scale […]

Read more
11Dec

Center denies permission to Mamata Banerjee to travel to Nepal, party alleges ‘Vindictive Politics’

Posted by: admin Categories: Covid19
Comments Off on Center denies permission to Mamata Banerjee to travel to Nepal, party alleges ‘Vindictive Politics’

The Ministry of External Affairs (MEA) denied permission to West Bengal Chief Minister Mamata Banerjee to travel to neighboring Nepal. She was invited there to participate in a convention.  It seems that the political tussle between BJP led Center and West Bengal Chief Minister Mamata Banerjee is not going to get over anytime soon. Banerjee […]

Read more
11Dec

”Ralph Baric, Synthetic SARS Spike Proteins, Gilead Sciences & Remdesivir” LIVE with Andy

Posted by: admin Categories: Covid19
Comments Off on ”Ralph Baric, Synthetic SARS Spike Proteins, Gilead Sciences & Remdesivir” LIVE with Andy

Andy Dybala discusses Ralph Barics association with Gilead Sciences and the creation of Remdesivir through NIAID funding. We also discuss how Ralph Baric and his lab synthetically added the spike protein to SARS-CoV in 2006. We also throw in some GoF Research & CRISPR research. Follow Andy: Patreon: www.patreon.com/andydybala Twitter: twitter.com/LivewithAndy NeighborhoodNewsStudio.com/ Share | Download […]

Read more
11Dec

Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation Process

Posted by: admin Categories: Covid19
Comments Off on Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation Process

Background: Given the challenges associated with timely delivery of monoclonal antibody (mAb) therapy to outpatients with coronavirus disease 2019 (COVID-19) who are most likely to benefit, it is critical to understand the effectiveness of such therapy outside the context of clinical trials. Methods: This was a case-control study of 1257 adult outpatients with COVID-19, ≥65 […]

Read more
11Dec

Has REGEN-COV (casirivimab + imdevimab) been found to induce lytic reactivation of the oncogenic virus HHV-8 (KSHV)? : medicine

Posted by: admin Categories: Covid19
Comments Off on Has REGEN-COV (casirivimab + imdevimab) been found to induce lytic reactivation of the oncogenic virus HHV-8 (KSHV)? : medicine

Mid-2021, researchers at UAMS published a paper called “SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus,” in which they studied the effects 6 treament options. However, the REGEN-COV monoclonal antibody treatment was not among the treatment options studied. Is there a follow-up study addressing REGEN-COV’s effects on HHV-8? HHV-8 plays a […]

Read more
10Dec

Quercetin and remdesivir Interactions – Drugs.com

Posted by: admin Categories: Covid19
Comments Off on Quercetin and remdesivir Interactions – Drugs.com

This report displays the potential drug interactions for the following 2 drugs: Quercetin (bioflavonoids) remdesivir Edit list (add/remove drugs) Interactions between your drugs No interactions were found between Quercetin and remdesivir. This does not necessarily mean no interactions exist. Always consult your healthcare provider. Quercetin A total of 1 drugs are known to interact with […]

Read more
8Dec

Therapeutic interventions of remdesivir in diabetic and nondiabetic COVID-19 patients: A prospective observational study conducted on Pakistani population. | J Med Virol;93(12): 6732-6736, 2021 Dec.

Posted by: admin Categories: Covid19
Comments Off on Therapeutic interventions of remdesivir in diabetic and nondiabetic COVID-19 patients: A prospective observational study conducted on Pakistani population. | J Med Virol;93(12): 6732-6736, 2021 Dec.

ABSTRACT We aimed to investigate the interventions of remdesivir in both diabetic and nondiabetic individuals who were suffering from a severe infection of novel coronavirus disease (COVID-19). In this study, we aimed to explore the relationship between therapeutic effectiveness of remdesivir and complications of diabetes mellitus by observing the recovery period among diabetic and nondiabetic […]

Read more
7Dec

Cipremi 100mg Injection | Exporter | Supplier | Wholesaler

Posted by: admin Categories: Covid19
Comments Off on Cipremi 100mg Injection | Exporter | Supplier | Wholesaler

Description Cipremi 100mg Injection is a broad-spectrum antiviral medicine. It is used for the treatment of suspected or laboratory-confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. The medicine decreases the viral load in the body and speeds up the recovery process. How Cipremi 100mg Injection is used? Cipremi 100mg Injection works by […]

Read more
« Older posts
Newer posts »